Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases
Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases
Not yet recruiting · NCT07660783 · Registry updated 2026-06-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases | Bone Marrow Failure, Bone Marrow Failure Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Lymphohistiocytosis, Hemophagocytic, Primary Immunodeficiency Diseases, bone marrow disorder, hematologic disorder, hereditary disease, histiocytosis, immune system disorder, inborn error of immunity, inherited hemoglobinopathy, lymphatic system disorder, non-Langerhans cell histiocytosis | Not yet recruiting | Phase 2 | 2026-06-22 | NCT07660783 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fred Hutchinson Cancer Center | 123 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| Seattle Children's Hospital | Seattle | United States | 281 |